Stephanie Lao, MD
Obstetrics & Gynecology · Los Angeles, CANPI 1073011169
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 30.9% of the total. Reporting peaked in 2021 at $688 and has fallen 88.4% since, to $80 in 2025.
Across 83 payments — averaging $18.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$484
- Myovant Sciences Inc.$140
- Daiichi Sankyo Inc.$128
- Hologic Sales And Service, LLC$78
- Therapeuticsmd, Inc.$77
- Roche Diagnostics Corporation$69
- plus $590 from 20 others
What the payments were for
- Food & beverage$1,567100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $484 |
| Myovant Sciences Inc. | 11 | $140 |
| Daiichi Sankyo Inc. | 6 | $128 |
| Hologic Sales And Service, LLC | 4 | $78 |
| Therapeuticsmd, Inc. | 4 | $77 |
| Roche Diagnostics Corporation | 3 | $69 |
| Evofem Biosciences, Inc. | 4 | $63 |
| Bayer | 3 | $60 |
| Organon | 3 | $53 |
| Exeltis, USA Inc. | 2 | $39 |
| Coopersurgical, Inc. | 2 | $38 |
| Coloplast | 2 | $38 |
| GE HealthCare | 1 | $38 |
| Pfizer | 2 | $31 |
| Biogen | 1 | $29 |
| Novo Nordisk | 1 | $29 |
| Merck | 1 | $28 |
| Boston Scientific | 1 | $24 |
| Intuitive Surgical | 1 | $23 |
| Shield Therapeutics Inc | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Agile Therapeutics, Inc. | 1 | $18 |
| Corium, LLC | 1 | $17 |
| Dysis Medical, Inc. | 1 | $12 |
| Aspira Women's Health Inc | 1 | $6 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $6 |
How this compares
$1,567 in reported general payments places this provider in the 70th percentile of 3,784 obstetrics & gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OsphenaOspemifene | 18 | $5,203 |
| Estradiol | 22 | $1,756 |
| Estradiol (Twice Weekly)Estradiol | 17 | $929 |
| ProgesteroneProgesterone, Micronized | 15 | $507 |
| Clobetasol Propionate | 11 | $329 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $231 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Los Angeles
- Malcolm MunroLos Angeles$609K
- Ramon YeraLos Angeles$296K
- Ritu SalaniLos Angeles$158K
- Aela PaizLos Angeles$131K
- Roy SilverLos Angeles$57K
- Karen MannLos Angeles$50K
- Sebhat AfeworkLos Angeles$42K
- Nicole BenderLos Angeles$35K
- Christine SterlingLos Angeles$30K
- Steve YuNorthridge$964K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.